Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to investigate the pharmacodynamic and pharmacokinetic
parameters of a novel furosemide formulation administered subcutaneously as compared to oral
furosemide.